Advanced Nitric Oxide Generating Nanomedicine for Therapeutic Applications.
Zhixiong WangAlbert J JinZhen YangWei HuangPublished in: ACS nano (2023)
Nitric oxide (NO), a gaseous transmitter extensively present in the human body, regulates vascular relaxation, immune response, inflammation, neurotransmission, and other crucial functions. Nitrite donors have been used clinically to treat angina, heart failure, pulmonary hypertension, and erectile dysfunction. Based on NO's vast biological functions, it further can treat tumors, bacteria/biofilms and other infections, wound healing, eye diseases, and osteoporosis. However, delivering NO is challenging due to uncontrolled blood circulation release and a half-life of under five seconds. With advanced biotechnology and the development of nanomedicine, NO donors packaged with multifunctional nanocarriers by physically embedding or chemically conjugating have been reported to show improved therapeutic efficacy and reduced side effects. Herein, we review and discuss recent applications of NO nanomedicines, their therapeutic mechanisms, and the challenges of NO nanomedicines for future scientific studies and clinical applications. As NO enables the inhibition of the replication of DNA and RNA in infectious microbes, including COVID-19 coronaviruses and malaria parasites, we highlight the potential of NO nanomedicines for antipandemic efforts. This review aims to provide deep insights and practical hints into design strategies and applications of NO nanomedicines.
Keyphrases
- nitric oxide
- cancer therapy
- sars cov
- heart failure
- pulmonary hypertension
- immune response
- drug delivery
- nitric oxide synthase
- wound healing
- endothelial cells
- plasmodium falciparum
- hydrogen peroxide
- single molecule
- coronavirus disease
- oxidative stress
- coronary artery
- coronary artery disease
- postmenopausal women
- kidney transplantation
- bone mineral density
- cell free
- nucleic acid
- quality improvement
- current status
- percutaneous coronary intervention
- pulmonary arterial hypertension
- risk assessment
- left ventricular
- atrial fibrillation
- human health
- acute coronary syndrome
- case control